VITUS Post-Market Registry

Who May Qualify: - Consecutive patients intended to be or treated by the VITUS peripheral drug-coated dilatation catheter as per physicians' decision and according to IFU in the setting of routine clinical care are entered into the registry - The lesion to be treated should be shorter than the nominal length of balloon at a reference vessel diameter of 2.0 mm up to 7.0 mm. - If lesion is longer than the individual balloon, more than one DCB can be used for longer lesions with the mandatory overlapping balloons of 10mm to avoid any geographical miss. - Rutherford clinical categories 2-5 Who Should NOT Join This Trial: - The patients are excluded from registration if ANY of the following conditions apply: - High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons) - Currently participating in another investigational drug or device study in which a routine angiographic follow-up in peripheral arteries is planned - A life expectancy of \<1year - Explicit refusal of participation in the registry - Residual stenosis \>50% after vessel preparation Always talk to your doctor about whether this trial is right for you.